Cargando…
New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease
Oral branched-chain amino acids (BCAAs) might benefit patients with advanced liver disease. We assess its effects on prognosis compared with control from the meta-analysis. METHODS: Study end points were development of hepatic encephalopathy (HE), hepatocellular carcinoma (HCC), mortality, and overa...
Autores principales: | Lee, Hankil, Yoo, Jeong-Ju, Ahn, Sang Hoon, Kim, Beom Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780118/ https://www.ncbi.nlm.nih.gov/pubmed/36250703 http://dx.doi.org/10.14309/ctg.0000000000000542 |
Ejemplares similares
-
Oral Branched-Chain Amino Acids Supplementation in Athletes: A Systematic Review
por: Martinho, Diogo V., et al.
Publicado: (2022) -
Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression
por: Lee, Hankil, et al.
Publicado: (2021) -
Branched-Chain Amino Acids and Branched-Chain Keto Acids in Hyperammonemic States: Metabolism and as Supplements
por: Holeček, Milan
Publicado: (2020) -
Effects of enriched branched-chain amino acid supplementation on sarcopenia
por: Ko, Chun-Hung, et al.
Publicado: (2020) -
Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties
por: Marrone, Giuseppe, et al.
Publicado: (2023)